Drugs / Felypressin
Felypressin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04236115 Comparator | Sep 2017 → Apr 2018 | — | Taibah University | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Felypressin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04236115 ↗ |
| Known as | Felipresina | ChEMBL registry synonym — accepted as the source's own label CHEMBL3185126 ↗ |
| Known as | Felypressine | ChEMBL registry synonym — accepted as the source's own label CHEMBL3185126 ↗ |
| Known as | PLV-2 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3185126 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL3185126 ↗ |